Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ)

PRESS RELEASE

published on 03/21/2024 at 10:00, 2 years 5 months ago

Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply
Eckert & Ziegler BEBIG GmbH, a subsidiary of Eckert & Ziegler SE, obtains MDR certification for proprietary prostate seeds from DEKRA Certification B.V., ensuring patient safety and long-term supply within the EU

DEKRA Certification Eckert & Ziegler MDR Certification Prostate Seeds Brachytherapy
BRIEF

published on 03/19/2024 at 19:51, 2 years 5 months ago

Eckert & Ziegler Announces Dividend Cut to Fund Future Investments

Investment Eckert & Ziegler Financial Forecast Dividend Reduction Radiopharmaceuticals
PRESS RELEASE

published on 03/19/2024 at 19:46, 2 years 5 months ago

EQS-Adhoc: Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024.
Eckert & Ziegler reduces dividend to fund future investments, aiming for earnings growth in 2024. Details on financial performance and strategic moves disclosed

Financial Performance Eckert & Ziegler Earnings Growth Dividend Reduction Strategic Investments
BRIEF

published on 03/19/2024 at 10:58, 2 years 5 months ago

Eckert & Ziegler Transitions to Societas Europaea

Corporate Governance Shareholder Rights Eckert & Ziegler SE Societas Europaea Legal Transition
PRESS RELEASE

published on 03/19/2024 at 10:53, 2 years 5 months ago

Eckert & Ziegler Completes Change of Legal Form to SE
Eckert & Ziegler completes change of legal form to SE, maintaining shareholder equity and operations. The company is a leading specialist in nuclear medicine and radiation therapy

Eckert & Ziegler Legal Form SE Nuclear Medicine Radiation Therapy
BRIEF

published on 02/28/2024 at 10:00, 2 years 6 months ago

Eckert & Ziegler Expands Ga-68 Activities in Japan in Collaboration with Novartis

Eckert & Ziegler Medical Imaging Diagnostic Gallium-68 Novartis Pharma KK
PRESS RELEASE

published on 02/28/2024 at 10:00, 2 years 6 months ago

Eckert & Ziegler Extends Ga-68 Activities in Japan
Eckert & Ziegler extends Ga-68 activities in Japan in alliance with Novartis Pharma K.K. Clinical trial with GalliaPharm generator for Ga-68. Collaboration to enhance cancer therapies and diagnostics in Japan

Eckert & Ziegler Clinical Trial Japan Ga-68 Radiopharmaceutical Industry
PRESS RELEASE

published on 01/31/2024 at 14:00, 2 years 7 months ago

Eckert & Ziegler to Supply Nucleus Radiopharma with Therapeutic Radioisotopes Ac-225 and Lu-177
Eckert & Ziegler to supply Nucleus Radiopharma with therapeutic radioisotopes Ac-225 and Lu-177 for cancer care, enabling advancement in radiotherapies and clinical development

Cancer Care Eckert & Ziegler Nucleus Radiopharma Therapeutic Radioisotopes Radiotherapies
PRESS RELEASE

published on 01/23/2024 at 08:00, 2 years 7 months ago

Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals
Eckert & Ziegler (ISIN DE0005659700, SDAX) and Full-Life Technologies have signed an agreement for the supply of Actinium-225 (Ac-225), a radionuclide for developing the next generation of therapeutic radiopharmaceuticals. The agreement aims to increase access to Ac-225, which is vital for advancing the development and clinical research efforts of Full-Life Technologies.

Clinical Research Eckert & Ziegler Full-Life Technologies Actinium-225 Supply Agreement Therapeutic Radiopharmaceuticals
PRESS RELEASE

published on 10/23/2023 at 09:00, 2 years 10 months ago

Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials

Published on 09/16/2026 at 15:00, 44 minutes ago

2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 1 hour 44 minutes ago

Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 13:30, 2 hours 14 minutes ago

Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Published on 09/16/2026 at 13:23, 2 hours 21 minutes ago

SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 13:15, 2 hours 29 minutes ago

Impauer Technologies Announces Launch Of New Corporate Website And Provides OTC Symbol Update

View all ACCESSWIRE

Published on 09/16/2026 at 15:36, 8 minutes ago

Custodian Property Income REIT plc: Share Buyback
Published on 09/16/2026 at 15:04, 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/16/2026 at 15:04, 40 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 09/16/2026 at 15:03, 40 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 09/16/2026 at 15:02, 41 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

View all EQS

Published on 09/16/2026 at 07:00, 8 hours 44 minutes ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 21 hours 44 minutes ago

Report on the Combined General Meeting of the 10th of September 2026
Published on 09/15/2026 at 17:45, 21 hours 59 minutes ago

EURAZEO COMPLETES THE ACQUISITION OF NETCO GROUP
Published on 09/15/2026 at 17:43, 22 hours 1 minute ago

Aéroports de Paris S.A - August 2026 traffic figures
Published on 09/15/2026 at 17:01, 22 hours 42 minutes ago

Number of shares and voting rights - August 2026 (In French only)

View all LES ECHOS COMFI WIRE

News